医学
氢吗啡酮
羟考酮
吗啡
鸦片剂
类阿片
药理学
左旋孤儿醇
芬太尼
羟吗啡酮
药效学
慢性疼痛
临床药理学
药代动力学
阿芬太尼
不利影响
麻醉
内科学
受体
(+)-纳洛酮
精神科
作者
Andrea M. Trescot,Sukdeb Datta,Marion Lee,Hans Nørgaard Hansen
出处
期刊:PubMed
[National Institutes of Health]
日期:2008-03-01
卷期号:11 (2 Suppl): S133-53
被引量:204
摘要
Mu agonists have been an important component of pain treatment for thousands of years. The usual pharmacokinetic parameters (half-life, clearance, volume of distribution) of opioids have been known for some time. However, the metabolism has, until recently, been poorly understood, and there has been recent interest in the role of metabolites in modifying the pharmacodynamic response in patients, in both analgesia and adverse effects. A number of opioids are available for clinical use, including morphine, hydromorphone, levorphanol, oxycodone, and fentanyl. Advantages and disadvantages of various opioids in the management of chronic pain are discussed.This review looks at the structure, chemistry, and metabolism of opioids in an effort to better understand the side effects, drug interactions, and the individual responses of patients receiving opioids for the treatment of intractable pain.Mu receptor agonists and agonist-antagonists have been used throughout recent medical history for the control of pain and for the treatment of opiate induced side effects and even opiate withdrawal syndromes.
科研通智能强力驱动
Strongly Powered by AbleSci AI